Growth Metrics

Innoviva (INVA) Non-Current Deferred Tax Liability (2022 - 2026)

Innoviva posted quarterly Non-Current Deferred Tax Liability of $72.8 million for Q1 2026, up 129.08% on a QoQ basis from $31.8 million in Q4 2025.

Innoviva (INVA) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $72.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $72.8 million; the trailing twelve-month figure through Mar 2026 stood at $72.8 million (changed N/A YoY), and the FY2025 full-year result was $31.8 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $72.8 million, up from $31.8 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $72.8 million in Q1 2026 and bottomed at $360000.0 in Q3 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $5.4 million (2023), against an average of $17.2 million.
  • The widest annual swing landed in 2023, when Non-Current Deferred Tax Liability slumped 90.24%; it then retreated 29.4% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $5.8 million in 2022, then plunged by 90.24% to $563000.0 in 2023, then surged by 576.2% to $3.8 million in 2024, then jumped by 735.12% to $31.8 million in 2025, then jumped by 129.08% to $72.8 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $72.8 million (Q1 2026), $31.8 million (Q4 2025), and $3.8 million (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 72.83 Mn
Mar 31, 2026 72.83 Mn
Dec 31, 2025 31.79 Mn
Dec 31, 2025 31.79 Mn
Mar 31, 2024 3.81 Mn
Mar 31, 2024 3.81 Mn
Dec 31, 2023 563,000.00
Dec 31, 2023 563,000.00
Mar 31, 2023 5.39 Mn
Mar 31, 2023 5.39 Mn
Dec 31, 2022 5.77 Mn
Dec 31, 2022 5.77 Mn
Sep 30, 2022 360,000.00
Sep 30, 2022 360,000.00